Genotropin (somatropin) / Pfizer 
Welcome,         Profile    Billing    Logout  

6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Genotropin (somatropin) / Pfizer
2012-000432-26: Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome Verkennende studie naar de stofwisseling en groei-effecten van groeihormoon behandeling bij kinderen met Kabuki syndroom

Ongoing
4
20
Europe
Genotropin, Genotropin, Genotropin
Maastricht University Medical Centre, Pfizer
Kabuki Syndrome (KS, OMIM 147920) with a mutation in MLL2 gene. Kabuki Syndroom (KS, OMIM 147920) met een mutatie in MLL2 gen.
 
 
2011-001313-14: Young adult Prader-Willi Study Effects of Growth Hormone after final height: A clinical care study to the optimal dosage of growth hormone in young adults with PWS. Jong volwassenen Prader Willy studie Effecten van groeihormoon nadat de eindlengte bereikt is: Een klinische studie naar de optimale dosering groeihormoon in jong volwassenen met PWS.

Ongoing
3
20
Europe
Genotropin, GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made., GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made.
Dutch growth research foundation, Pfizer
Prader Willi Syndrome
 
 
2018-000918-38: STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF WEEKLY GROWTH HORMONE (SOMATROGON) VERSUS DAILY GROWTH HORMONE (GENOTROPIN®) INJECTIONS IN CHILDREN WITH GROWTH HORMONE DEFICIENCY

Not yet recruiting
3
90
Europe
Somatrogon, Genotropin, PF-06836922, Solution for injection, Powder and solvent for solution for injection, Genotropin, Genotropin GoQuick
Pfizer Inc., Pfizer Inc.
Growth Hormone Deficiency in Children, Treatment of children with growth failure due to growth hormone deficiency, Diseases [C] - Hormonal diseases [C19]
 
 
NCT04697381: Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

Completed
3
33
Japan
somatropin - GH naïve pediatric cohort, somatropin - GH treated cohort, somatropin - adult cohort
Pfizer
Prader-Willi Syndrome
12/22
04/24
NCT03038594: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

Completed
2/3
13
US
Somatropin, Genotropin, Growth Hormone (GH), 0.09% Saline Solution, Placebo, Control
The University of Texas Medical Branch, Galveston, United States Department of Defense, Pfizer
Burns, Growth Hormone Treatment
11/21
11/21
GGAP, NCT04484051: Growth Hormone Study in Adults With Prader-Willi Syndrome

Not yet recruiting
N/A
25
Europe
Somatropin, Genotropin (5,0 mg/mL), Placebo
Erasmus Medical Center, Foundation for Prader-Willi Research, Prader-Willi Fonds
Prader-Willi Syndrome
09/26
10/26

Download Options